Combination Therapy of Alpha-Lipoic Acid, Gliclazide and Ramipril Protects Against Development of Diabetic Cardiomyopathy via Inhibition of TGF-β/Smad Pathway

• Автори: George J. Dugbartey (Автор), Quinsker L. Wonje (Автор), Karl K. Alornyo (Автор), Louis Robertson (Автор), Ismaila Adams (Автор), Vincent Boima (Автор), Samuel D. Mensah (Автор)
• Формат: Книга
• Опубліковано: Frontiers Media S.A., 2022-03-01T00:00:00Z.
• Предмети: article
• Онлайн доступ: Connect to this object online.

Background: Diabetic cardiomyopathy (DCM) is a major long-term complication of diabetes mellitus, accounting for over 20% of annual mortality rate of diabetic patients globally. Although several existing anti-diabetic drugs have improved glycemic status in diabetic patients, prevalence of DCM is sti...